CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. FDX
4. CBRS
5. USO
6. SPY
7. HTZ
8. KBH
9. HON
10. GOOGL

Go back to CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

CytomX Therapeutics (CTMX) Misses Q3 EPS by 2c

November 8, 2022 4:19 PM EST

CytomX Therapeutics (NASDAQ: CTMX) reported Q3 EPS of ($0.35), $0.02 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $16.92 million versus the consensus estimate of $18.27 million.

For earnings history and earnings-related data on CytomX Therapeutics (CTMX) click here.

... More